» Authors » Aaron R Mangold

Aaron R Mangold

Explore the profile of Aaron R Mangold including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 95
Citations 421
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
McGillivray E, Ashouri K, Chatziioannou E, Ocejo Gallegos J, Zarka J, Kechter J, et al.
Br J Dermatol . 2024 Oct; 192(2):316-326. PMID: 39438074
Background: Combination immune checkpoint blockade targeting programmed cell death protein 1 (PD-1) and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) leads to high response rates and improved survival in patients with...
12.
Hughes A, Li X, Lehman J, Nelson S, DiCaudo D, Mudappathi R, et al.
JID Innov . 2024 Oct; 4(6):100296. PMID: 39391813
Drug repurposing is an attractive strategy for therapy development, particularly in rare diseases where traditional drug development approaches may be challenging owing to high cost and small numbers of patients....
13.
Gelfand J, Armstrong A, Lim H, Feldman S, Johnson S, Claiborne W, et al.
JAMA Dermatol . 2024 Sep; 160(12):1320-1328. PMID: 39319513
Importance: Office-based phototherapy is cost-effective for psoriasis but difficult to access. Home-based phototherapy is patient preferred but has limited clinical data, particularly in patients with darker skin. Objective: To compare...
14.
Granger E, Ran N, Groover M, Koyfman S, Vidimos A, Wysong A, et al.
J Am Acad Dermatol . 2024 Jul; 91(5):957-960. PMID: 38971189
No abstract available.
15.
Laughlin B, Van Der Walt C, Mangold A, Breen W, Rosenthal A, Lester S, et al.
Adv Radiat Oncol . 2024 Jun; 9(7):101502. PMID: 38846486
Purpose: Low-dose total skin electron beam therapy (TSEBT) is a proven treatment for managing cutaneous T-cell lymphoma (CTCL) and Sezary syndrome with skin burden. We performed a retrospective comparison of...
16.
Murrell D, Joly P, Werth V, Ujiie H, Worm M, Mangold A, et al.
Adv Ther . 2024 May; 41(7):3014-3015. PMID: 38787464
No abstract available.
17.
Aragon Sierra A, Hwang A, Kechter J, Mangold A, Nagaraja V, DiCaudo D
JAAD Case Rep . 2024 Apr; 47:32-34. PMID: 38576903
No abstract available.
18.
Laughlin B, Zaniletti I, Foster M, Lucido J, Mangold A, Rosenthal A, et al.
Anticancer Res . 2024 Mar; 44(4):1491-1497. PMID: 38537978
Background/aim: Total skin electron beam therapy (TSEBT) is an effective treatment for managing cutaneous T-cell lymphoma (CTCL), but may result in unnecessary toxicity. With the production of a custom rolling...
19.
Yamanaka-Takaichi M, Watanabe M, Comfere N, Sokumbi O, Akpala C, Todd A, et al.
J Am Acad Dermatol . 2024 Mar; 90(6):1289-1291. PMID: 38483432
No abstract available.
20.
Murrell D, Joly P, Werth V, Ujiie H, Worm M, Mangold A, et al.
Adv Ther . 2024 Mar; 41(7):2991-3002. PMID: 38443648
Background: Bullous pemphigoid (BP) is a rare, autoimmune, blistering skin disease associated with high disease burden, profoundly decreased quality of life and increased morbidity. Emerging evidence supports an important role...